Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease
Authors:
- 1 September 2001
- journal article
- Published by Elsevier in Neuroscience
- Vol. 106 (3) , 603-612
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neuronsProceedings of the National Academy of Sciences, 1999
- Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 ExpressionJournal of Biological Chemistry, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- Excitotoxic cell deathJournal of Neurobiology, 1992
- Cerebral hypoxia: some new approaches and unanswered questionsJournal of Neuroscience, 1990
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976